Investing

Humacyte : HUMA

HUMA

Stock Data

$1.08

$0.03 (2.70%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Humacyte Inc is a pioneering biotechnology firm based in Durham, North Carolina, focused on creating revolutionary human tissue replacements. With a strong emphasis on engineering human acellular vessels (HAVs), the company aims to transform treatments for a wide array of medical conditions, including vascular diseases, diabetes, and more. Their innovative HAVs are designed for universal implantation, avoiding immune rejection. Founded in 2004, Humacyte's work spans from vascular repair and hemodialysis access to potential applications in heart surgery and cellular therapy delivery.

All Humacyte Articles

2 Articles

Eric Bleeker | Jun 23, 2024 at 5:00 PM EDT

Beyond Penny Stocks: Congressman Buys a Penny Crypto Worth Ten Cents

On April 18th, 24/7 Wall Street alerted investors to a recent stock purchase by Alabama Senator Tommy Tuberville of a…

Eric Bleeker | Apr 18, 2024 at 4:54 PM EDT

A U.S. Senator Just Bought this Tiny Stock – It’s Up 15% Today

Tommy Tuberville, a Republican Senator from the state of Alabama, disclosed 19 new stock trades on April 15th, and one…